Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy
Date
2010
Authors
Hiwase, D.
White, D.
Zrim, S.
Saunders, V.
Vaz de Melo, J.
Hughes, T.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Leukemia, 2010; 24(3):658-660
Statement of Responsibility
DK Hiwase, D White, S Zrim, V Saunders, J V Melo and T P Hughes